REUTERS
October 12, 2020 at 14:50 JST
An electron microscope image of the new coronavirus isolated by the National Institute of Infectious Diseases (The National Institute of Infectious Diseases via the Asahi Shimbun)
SEOUL--South Korean drugmaker Celltrion Inc. said on Monday it has received regulatory approval for Phase 3 clinical trials of an experimental COVID-19 treatment.
The approval comes as the company plans to seek conditional approval for its antibody drug, CT-P59, for emergency use by the end of this year.
The treatment, the most advanced antibody drug in terms of research in South Korea, is directed against the surface of the virus and designed to block it from locking on to human cells.
The third stage trials will be conducted on some 1,000 asymptomatic coronavirus patients and those who have come into close contact with COVID-19 patients in Korea, Celltrion said in a statement.
The Ministry of Food and Drug Safety recently approved a Phase 2/3 study on patients with mild and moderate cases of COVID-19, Lee Sang-joon, Celltrion’s senior executive vice president, told Reuters.
Celltrion began commercial production of the drug in September--likely to amount to around 1 million doses--in anticipation of demand in both domestic and overseas markets.
In July, Celltrion separately launched overseas human trials of its treatment in Britain.
S. Korea’s Green Cross seeks phase 2 trials of COVID-19 plasma drug
July 29, 2020
Ministry speeds approval process for Avigan to treat COVID-19
May 13, 2020
Japan to approve drug remdesivir for treatment of COVID-19
April 28, 2020Fujifilm says COVID-19 drug research may drag on into July
June 8, 2020Fujifilm’s Avigan inconclusive in COVID-19 patients in Japan trial
July 10, 2020
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series about Japanese-Americans and their memories of World War II
